Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745224 · ClinicalTrials.gov registry record · NA
Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
A NA study, sponsored by Cynosure.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01745224: Clinical Trial NA study, sponsored by Cynosure.
NCT01745224 is a NA study that was terminated before completion, run by Cynosure. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01745224, a NA study, was terminated before completion, sponsored by Cynosure.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This proof of concept study will be conducted to assess the aesthetic improvement in refractory mixed type melasma in subjects treated with two FDA 510K approved devices: Q Switched Nd: YAG Laser vs. Alex TriVantage
Primary Outcome
The Global Aesthetic Improvement scale was used to determine the amount of improvement. This scale ranges from 1 to 5, where 1 is very much improved, 2 is much improved, 3 is improved, 4 is no change, and 5 is worsened.
Interventions
- DEVICE Revlite Q switched Nd:YAG
- DEVICE Trivantage Q switched Nd: YAG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-07 |
| Phase | NA |
Why NCT01745224 stopped before completion
NCT01745224 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Revlite Q switched Nd:YAG is the first listed.
NCT01745224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01745224 about?
NCT01745224 is a clinical study titled "Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma". This proof of concept study will be conducted to assess the aesthetic improvement in refractory mixed type melasma in subjects treated with two FDA 510K approved devices: Q Switched Nd: YAG Laser vs. Alex TriVantage
What is the current status of trial NCT01745224?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2012-07. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01745224?
The interventions under investigation include: Revlite Q switched Nd:YAG (DEVICE), Trivantage Q switched Nd: YAG (DEVICE).
Who is sponsoring clinical trial NCT01745224?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01745224's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia